SCHEMBL260558

SCHEMBL260558

CC(C)n1c2c(=O)ccc(=O)c2c2c(=O)c3ccccc3c21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 4/20 0.71
CDC25C P30307 4/20 0.71
CSNK2A2 P19784 2/20 0.52
CSNK2B P67870 2/20 0.52
CSNK2A1 P68400 2/20 0.52
ABCG2 Q9UNQ0 3/20 0.40
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 3/20 0.33
HTT P42858 1/20 0.33
PRKD3 O94806 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33
PRKCH P24723 1/20 0.33
PRKCI P41743 1/20 0.33
PRKCE Q02156 1/20 0.33
PRKCQ Q04759 1/20 0.33
PRKCZ Q05513 1/20 0.33
PRKCD Q05655 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL263528 0.69 CSNK2A2 (1.00) CDC25ACDC25CCSNK2A2CSNK2BCSNK2A1
SCHEMBL261654 0.68 CSNK2A2 (0.76) CDC25ACDC25CCSNK2A2CSNK2BCSNK2A1
SCHEMBL13424851 0.67 S100A4 (0.51) CDC25ACDC25CALDH1A1L3MBTL1POLB
SCHEMBL14160799 0.64 ALDH1A1 (0.53) CDC25ACDC25CALDH1A1L3MBTL1POLB
SCHEMBL25702411 0.63 CDC25A (0.43) CDC25ACDC25CALDH1A1L3MBTL1POLB
SCHEMBL7905111 0.62 S100A4 (0.52) CSNK2A2CSNK2BCSNK2A1ABCG2ALDH1A1
SCHEMBL19845762 0.62 HPRT1 (0.46) CDC25ACDC25CALDH1A1L3MBTL1CYP1A2
SCHEMBL25702432 0.62 CDC25A (0.42) CDC25ACDC25CALDH1A1L3MBTL1POLB
SCHEMBL21561008 0.61 CDC25A (0.51) CDC25ACDC25CALDH1A1CYP1A2MEN1
SCHEMBL23072093 0.60 POLB (0.41) CDC25ACDC25CALDH1A1L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079691-B1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOUR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS UNIV DUESSELDORF H HEINE (DE) 2013-08-14 EP claimed
US-8133913-B2 Substituted indeno [1,2-b]indole derivatives as novel inhibitors of protein kinase CK2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids Heinrich-Heine Universitat Dusseldof (DE) 2012-03-13 US claimed
US-20100056599-A1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS HEINRICH-HEINE UNIVERSITAT DUSSELDORF (DE) 2010-03-04 US claimed
EP-2079691-A1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOUR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS Heinrich-Heine-Universität Düsseldorf (DE) 2009-07-22 EP claimed
WO-2008040547-A1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOUR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS HEINRICH-HEINE UNIVERSITÄT DÜSSELDORF (DE) 2008-04-10 WO claimed
EP-2079691-B1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOUR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS UNIV DUESSELDORF H HEINE (DE) 2013-08-14 EP disclosed
US-8133913-B2 Substituted indeno [1,2-b]indole derivatives as novel inhibitors of protein kinase CK2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids Heinrich-Heine Universitat Dusseldof (DE) 2012-03-13 US disclosed
US-20100056599-A1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS HEINRICH-HEINE UNIVERSITAT DUSSELDORF (DE) 2010-03-04 US disclosed
EP-2079691-A1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOUR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS Heinrich-Heine-Universität Düsseldorf (DE) 2009-07-22 EP disclosed
WO-2008040547-A1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOUR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS HEINRICH-HEINE UNIVERSITÄT DÜSSELDORF (DE) 2008-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056599-A1 SUBSTITUTED INDENO[1,2-B]INDOLE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN KINASE CK2 AND THEIR USE AS TUMOR THERAPEUTIC AGENTS, CYTOSTATICS AND DIAGNOSTIC AIDS CDK2, CSNK1A1, CDK1 CDC25A 233/4885CDC25C 222/4885CSNK2A2 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.